Search results
Results from the WOW.Com Content Network
Investors don't have to buy and hope they eventually make money. Pfizer is generously compensating its shareholders for their patience with a dividend that yields 6.3% at today's share price.
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Pfizer wasn’t one of them. The 10 stocks that made the cut ...
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Pfizer wasn’t one of them. The 10 stocks that made the cut ...
Pfizer: 6.72% yield The first ultra-high-yield dividend stock that makes for a no-brainer buy in the upcoming year is pharmaceutical juggernaut Pfizer (NYSE: PFE) .
Pfizer's trailing-12-month (TTM) revenue is $59.3 billion, whereas its TTM normalized diluted earnings per share (EPS) is $1.55. ... Pfizer Just Reassured Investors, but Is the Stock a Buy? Alex ...
The stock could be a smart buy now because the company wisely reinvested a large swath of the proceeds. Last year, Pfizer acquired Seagen, a cancer drug developer with four commercial-stage ...
The good news is that declining sales should soon end, and Pfizer can start replenishing its top line with growth from non-pandemic-related products. ... Before you buy stock in Pfizer, consider ...
The good news is that oncology should begin driving renewed growth once these products are entirely out of the picture. Analysts estimate that Pfizer's earnings could grow by an average of 10.7% ...